-
1
-
-
0019349510
-
The histiocytic disorders: A pathophysiologic analysis
-
Groopman JE, Golde DW: The histiocytic disorders: A pathophysiologic analysis. Ann Intern Med 94:95, 1981
-
(1981)
Ann Intern Med
, vol.94
, pp. 95
-
-
Groopman, J.E.1
Golde, D.W.2
-
2
-
-
0028264473
-
Langerhans'-cell histiocytosis (histiocytosis X) - A clonal proliferative disease
-
Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG: Langerhans'-cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N Engl J Med 331:154, 1994
-
(1994)
N Engl J Med
, vol.331
, pp. 154
-
-
Willman, C.L.1
Busque, L.2
Griffith, B.B.3
Favara, B.E.4
McClain, K.L.5
Duncan, M.H.6
Gilliland, D.G.7
-
3
-
-
0022574084
-
Histiocytosis X: A review of the etiology, pathology, staging, and therapy
-
Grundy P, Ellis R: Histiocytosis X: A review of the etiology, pathology, staging, and therapy. Med Pediatr Oncol 14:45, 1986
-
(1986)
Med Pediatr Oncol
, vol.14
, pp. 45
-
-
Grundy, P.1
Ellis, R.2
-
4
-
-
0025979143
-
Concepts in staging and clinical studies for treatment of Langerhans'cell histiocytosis
-
Komp DM: Concepts in staging and clinical studies for treatment of Langerhans'cell histiocytosis. Semin Oncol 18:18, 1991
-
(1991)
Semin Oncol
, vol.18
, pp. 18
-
-
Komp, D.M.1
-
5
-
-
0023173250
-
Pathology of histiocytosis
-
Jaffe R: Pathology of histiocytosis. Perspect Pediatr Pathol 9:4, 1987
-
(1987)
Perspect Pediatr Pathol
, vol.9
, pp. 4
-
-
Jaffe, R.1
-
6
-
-
0027534925
-
Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: Experience at a single institution
-
Egeler RM, de Kraker J, Voute PA: Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: Experience at a single institution. Med Pediatr Oncol 21:265, 1993
-
(1993)
Med Pediatr Oncol
, vol.21
, pp. 265
-
-
Egeler, R.M.1
De Kraker, J.2
Voute, P.A.3
-
7
-
-
0025768580
-
Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)
-
Viana MB, Oliverira BM, Silva CM, Rios Leite VH: Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X). Med Pediatr Oncol 19:289, 1991
-
(1991)
Med Pediatr Oncol
, vol.19
, pp. 289
-
-
Viana, M.B.1
Oliverira, B.M.2
Silva, C.M.3
Rios Leite, V.H.4
-
8
-
-
0021273833
-
The treatment of malignant histiocytosis
-
Tseng A Jr, Coleman CN, Cox RS, Colby TV, Turner RR, Horning SJ, Rosenberg SA: The treatment of malignant histiocytosis. Blood 64:48, 1984
-
(1984)
Blood
, vol.64
, pp. 48
-
-
Tseng A., Jr.1
Coleman, C.N.2
Cox, R.S.3
Colby, T.V.4
Turner, R.R.5
Horning, S.J.6
Rosenberg, S.A.7
-
9
-
-
0028010849
-
Newer purine analogues for treatment of hairy cell leukemia
-
Saven A, Piro L: Newer purine analogues for treatment of hairy cell leukemia. N Engl J Med 330:691, 1994
-
(1994)
N Engl J Med
, vol.330
, pp. 691
-
-
Saven, A.1
Piro, L.2
-
10
-
-
0028219970
-
2-chlorodeoxyadenosine: A newer purine analogue active in the treatment of indolent lymphoid malignancies
-
Saven A, Piro L: 2-Chlorodeoxyadenosine: A newer purine analogue active in the treatment of indolent lymphoid malignancies. Ann Intern Med 120:784, 1994
-
(1994)
Ann Intern Med
, vol.120
, pp. 784
-
-
Saven, A.1
Piro, L.2
-
11
-
-
0026536178
-
2-chlorodeoxyadenosine produces a high rate of complete hematologic remissions in relapsed myeloid leukemiaa
-
Santana VM, Mirro J Jr, Kearns C, Schell MJ, Crom W, Blakley RL: 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remissions in relapsed myeloid leukemiaa. J Clin Oncol 10:364, 1992
-
(1992)
J Clin Oncol
, vol.10
, pp. 364
-
-
Santana, V.M.1
Mirro J., Jr.2
Kearns, C.3
Schell, M.J.4
Crom, W.5
Blakley, R.L.6
-
12
-
-
0028221174
-
Complete hematologic remissions in chronic-phase, Philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosine
-
Saven A, Piro LD, Lemon RH, Figueroa ML, Kosty M, Ellison DJ, Beutler E: Complete hematologic remissions in chronic-phase, Philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosine. Cancer 73:2953, 1994
-
(1994)
Cancer
, vol.73
, pp. 2953
-
-
Saven, A.1
Piro, L.D.2
Lemon, R.H.3
Figueroa, M.L.4
Kosty, M.5
Ellison, D.J.6
Beutler, E.7
-
13
-
-
0025047556
-
Potent toxicity of 2-chlorodeoxyadeno sine towards human monocytes in vitro and in vivo: A novel approach to immunosuppressive therapy
-
Carrera CJ, Terai C, Lotz M, Curd JG, Piro LD, Beutler E, Carson DA: Potent toxicity of 2-chlorodeoxyadeno sine towards human monocytes in vitro and in vivo: A novel approach to immunosuppressive therapy. J Clin Invest 86:1480, 1990
-
(1990)
J Clin Invest
, vol.86
, pp. 1480
-
-
Carrera, C.J.1
Terai, C.2
Lotz, M.3
Curd, J.G.4
Piro, L.D.5
Beutler, E.6
Carson, D.A.7
-
14
-
-
0027214616
-
2-chlorodeoxy-adenosine to treat refractory histiocytosis X
-
Saven A, Figueroa ML, Piro LD, Rosenblatt JD: 2-Chlorodeoxy-adenosine to treat refractory histiocytosis X (Letter). N Engl J Med 329:734, 1993
-
(1993)
N Engl J Med
, vol.329
, pp. 734
-
-
Saven, A.1
Figueroa, M.L.2
Piro, L.D.3
Rosenblatt, J.D.4
-
15
-
-
0028607371
-
2-chlorodeoxyadenosine-induced complete remissions in Lanagerhans-cell histiocytosis
-
Saven A, Foon KA, Piro L: 2-Chlorodeoxyadenosine-induced complete remissions in Lanagerhans-cell histiocytosis. Ann Intern Med 121:430, 1994
-
(1994)
Ann Intern Med
, vol.121
, pp. 430
-
-
Saven, A.1
Foon, K.A.2
Piro, L.3
-
16
-
-
0023158882
-
Histiocytosis syndromes in children
-
Writing Group of the Histiocyte Society: Histiocytosis syndromes in children. Lancet 1:208, 1987
-
(1987)
Lancet
, vol.1
, pp. 208
-
-
-
17
-
-
0031012014
-
Langerhans'-cell histiocytosis in adults
-
Baumgartner I, von HochstetterA, Baumert B, Leutolf U, Follath F: Langerhans'-cell histiocytosis in adults. Med Pediatr Oncol 28:9, 1997
-
(1997)
Med Pediatr Oncol
, vol.28
, pp. 9
-
-
Baumgartner, I.1
Von Hochstetter, A.2
Baumert, B.3
Leutolf, U.4
Follath, F.5
-
18
-
-
0003678252
-
-
Philadelphia, PA, Lipincott
-
MacDonald JS, Haller DG, Mayer RJ: Manual of Oncologic Therapeutics. Philadelphia, PA, Lipincott, 1995
-
(1995)
Manual of Oncologic Therapeutics
-
-
MacDonald, J.S.1
Haller, D.G.2
Mayer, R.J.3
-
20
-
-
0022385561
-
The intermediate cell proliferative disorder: Report of a case manifesting as an unusual cutaneous histiocytosis
-
Wood GS, Hu C-H, Beckstead JH, Turner RR, Winkelmann RK: The intermediate cell proliferative disorder: Report of a case manifesting as an unusual cutaneous histiocytosis. J Dermatol Surg Oncol 11:1111, 1985
-
(1985)
J Dermatol Surg Oncol
, vol.11
, pp. 1111
-
-
Wood, G.S.1
Hu, C.-H.2
Beckstead, J.H.3
Turner, R.R.4
Winkelmann, R.K.5
-
21
-
-
0345637741
-
Clinical and pharmacologic studies of 2-chlorodeoxyadenosine (2-CdA) in children with advanced hematologic malignancies and solid tumors
-
abstr
-
Tan CTC, Guarino L, Tong WP, Wollner N, Finlay J, Meyers PA, Steinherz PG, Ghavimi F, Wong ET: Clinical and pharmacologic studies of 2-chlorodeoxyadenosine (2-CdA) in children with advanced hematologic malignancies and solid tumors. Blood 84:1195, 1995 (suppl 1, abstr)
-
(1995)
Blood
, vol.84
, Issue.SUPPL. 1
, pp. 1195
-
-
Tan, C.T.C.1
Guarino, L.2
Tong, W.P.3
Wollner, N.4
Finlay, J.5
Meyers, P.A.6
Steinherz, P.G.7
Ghavimi, F.8
Wong, E.T.9
-
22
-
-
16144362285
-
2-chlorodeoxyadenosine (2-CDA) for disorders of monohistiocytic (MO/HI) lineage
-
abstr
-
Wayne AS, Tan CTC, Arceci RJ, Barr R, Hurwitz CA, Pitel PA, Weinstein HJ, Favara BE: 2-Chlorodeoxyadenosine (2-CDA) for disorders of monohistiocytic (MO/HI) lineage. Blood 84:215, 1994 (suppl 1, abstr)
-
(1994)
Blood
, vol.84
, Issue.SUPPL. 1
, pp. 215
-
-
Wayne, A.S.1
Tan, C.T.C.2
Arceci, R.J.3
Barr, R.4
Hurwitz, C.A.5
Pitel, P.A.6
Weinstein, H.J.7
Favara, B.E.8
-
23
-
-
0030898525
-
Treatment of Langerhans' cell histiocytosis with 2-chlorodeoxyadenosine
-
Dimopoulos MA, Theodorakis M, Kostis E, Papadimitois C, Moulopoulos LA, Anastasiou-Nava M: Treatment of Langerhans' cell histiocytosis with 2-chlorodeoxyadenosine. Leuk Lymphoma 25:187, 1997
-
(1997)
Leuk Lymphoma
, vol.25
, pp. 187
-
-
Dimopoulos, M.A.1
Theodorakis, M.2
Kostis, E.3
Papadimitois, C.4
Moulopoulos, L.A.5
Anastasiou-Nava, M.6
-
24
-
-
0030795349
-
2-chlorodeoxy-adenosine (2-CdA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients
-
Stine KC, Saylors RL, Williams LL, Becton DZ: 2-Chlorodeoxy-adenosine (2-CdA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol 29:288, 1997
-
(1997)
Med Pediatr Oncol
, vol.29
, pp. 288
-
-
Stine, K.C.1
Saylors, R.L.2
Williams, L.L.3
Becton, D.Z.4
-
25
-
-
0022003367
-
Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes
-
Seto S, Carrera CJ, Kubota M, Wasson DB, Carson DA: Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J Clin Invest 75:377, 1985
-
(1985)
J Clin Invest
, vol.75
, pp. 377
-
-
Seto, S.1
Carrera, C.J.2
Kubota, M.3
Wasson, D.B.4
Carson, D.A.5
-
26
-
-
0028264426
-
Cladribine in treatment of chronic progressive multiple sclerosis
-
Sipe JC, Romine JS, Koziol JA, McMillan R, Zyroff J, Beutler E: Cladribine in treatment of chronic progressive multiple sclerosis. Lancet 344:9, 1994
-
(1994)
Lancet
, vol.344
, pp. 9
-
-
Sipe, J.C.1
Romine, J.S.2
Koziol, J.A.3
McMillan, R.4
Zyroff, J.5
Beutler, E.6
-
27
-
-
0029983154
-
The treatment of chronic progressive multiple sclerosis with cladribine
-
Beutler E, Sipe JC, Romine JS, Koziol JA, McMillan R, Zyroff J: The treatment of chronic progressive multiple sclerosis with cladribine. Proc Natl Acad Sci USA 93:1716, 1996
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 1716
-
-
Beutler, E.1
Sipe, J.C.2
Romine, J.S.3
Koziol, J.A.4
McMillan, R.5
Zyroff, J.6
-
28
-
-
0028338450
-
Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: Phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxy-adenosine
-
Juliusson G, Lenkei R, Liliemark J: Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: Phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxy-adenosine. Blood 83:3672, 1994
-
(1994)
Blood
, vol.83
, pp. 3672
-
-
Juliusson, G.1
Lenkei, R.2
Liliemark, J.3
-
29
-
-
0000538545
-
Restoration of lymphocyte subsets following 2-chlorodeoxy-adenosine remission induction in hairy cell leukemia
-
abstr
-
Carrera CJ, Piro LD, Saven A, Cox K, Beutler E, Carson DA, Kipps TJ: Restoration of lymphocyte subsets following 2-chlorodeoxy-adenosine remission induction in hairy cell leukemia. Blood 76:260a, 1990 (suppl 1, abstr)
-
(1990)
Blood
, vol.76
, Issue.SUPPL. 1
-
-
Carrera, C.J.1
Piro, L.D.2
Saven, A.3
Cox, K.4
Beutler, E.5
Carson, D.A.6
Kipps, T.J.7
-
30
-
-
0026023007
-
Cyclosporine therapy for advanced Langerhans' cell histiocytosis
-
abstr
-
Mahmoud HH, Wang WC, Murphy SB: Cyclosporine therapy for advanced Langerhans' cell histiocytosis. Blood 77:721, 1991 (abstr)
-
(1991)
Blood
, vol.77
, pp. 721
-
-
Mahmoud, H.H.1
Wang, W.C.2
Murphy, S.B.3
-
31
-
-
0015515283
-
Adenosine deaminase deficiency in two patients with severely impaired cellular immunity
-
Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ: Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067, 1972
-
(1972)
Lancet
, vol.2
, pp. 1067
-
-
Giblett, E.R.1
Anderson, J.E.2
Cohen, F.3
Pollara, B.4
Meuwissen, H.J.5
-
32
-
-
0024595398
-
Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia
-
Urba WJ, Baseler MW, Kopp WC, Steis RG, Clark JW, Smith JW II, Coggin DL, Longo DL: Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia. Blood 73:38, 1989
-
(1989)
Blood
, vol.73
, pp. 38
-
-
Urba, W.J.1
Baseler, M.W.2
Kopp, W.C.3
Steis, R.G.4
Clark, J.W.5
Smith J.W. II6
Coggin, D.L.7
Longo, D.L.8
-
33
-
-
0022622873
-
Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes
-
Seto S, Carrera CJ, Wasson DB, Carson DA: Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes. J Immunol 136:2839, 1986
-
(1986)
J Immunol
, vol.136
, pp. 2839
-
-
Seto, S.1
Carrera, C.J.2
Wasson, D.B.3
Carson, D.A.4
-
34
-
-
0028289425
-
2-chlorodeoxy-adenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia
-
Seymour JF, Kurzrock R, Freireich EJ, Estey EH: 2-Chlorodeoxy-adenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood 83:2906, 1994
-
(1994)
Blood
, vol.83
, pp. 2906
-
-
Seymour, J.F.1
Kurzrock, R.2
Freireich, E.J.3
Estey, E.H.4
-
35
-
-
0032530684
-
Long-term follow-up of patients with hairy cell leukemia after cladribine treatment
-
Saven A, Burian C, Koziol JA, Pollara B, Piro LD: Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 92:1918, 1998
-
(1998)
Blood
, vol.92
, pp. 1918
-
-
Saven, A.1
Burian, C.2
Koziol, J.A.3
Pollara, B.4
Piro, L.D.5
-
36
-
-
0031004465
-
Second cancer risk in hairy cell leukemia: Analysis of 350 patients
-
Kurzrock R, Strom SS, Estey E, O'Brien S, Keating MJ, Jiang H, Adams T, Talpaz M: Second cancer risk in hairy cell leukemia: Analysis of 350 patients. J Clin Oncol 15:1803, 1997
-
(1997)
J Clin Oncol
, vol.15
, pp. 1803
-
-
Kurzrock, R.1
Strom, S.S.2
Estey, E.3
O'Brien, S.4
Keating, M.J.5
Jiang, H.6
Adams, T.7
Talpaz, M.8
-
37
-
-
0032529702
-
Second malignancies in patients with hairy cell leukemia in British Columbia: A 20-year experience
-
Au WY, Klasa RJ, Gallagher R, Le N, Gascoyne RD, Connors JM: Second malignancies in patients with hairy cell leukemia in British Columbia: A 20-year experience. Blood 92:1160, 1998
-
(1998)
Blood
, vol.92
, pp. 1160
-
-
Au, W.Y.1
Klasa, R.J.2
Gallagher, R.3
Le, N.4
Gascoyne, R.D.5
Connors, J.M.6
-
38
-
-
0029909312
-
Langerhans cell histiocytosis in the adult
-
Malpas JS, Norton AJ: Langerhans cell histiocytosis in the adult. Med Pediatr Oncol 27:540, 1996
-
(1996)
Med Pediatr Oncol
, vol.27
, pp. 540
-
-
Malpas, J.S.1
Norton, A.J.2
-
39
-
-
0029918664
-
Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy
-
Saven A, Cheung WK, Smith I, Moyer M, Johannsen T, Rose E, Gollard R, Kosty M, Miller WE, Piro LD: Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy. J Clin Oncol 14:978, 1996
-
(1996)
J Clin Oncol
, vol.14
, pp. 978
-
-
Saven, A.1
Cheung, W.K.2
Smith, I.3
Moyer, M.4
Johannsen, T.5
Rose, E.6
Gollard, R.7
Kosty, M.8
Miller, W.E.9
Piro, L.D.10
-
40
-
-
0027056958
-
On the bioavailability of oral and subcutaneous 2-chloro-2′-deoxyadenosine in humans: Alternative routes of administration
-
Liliemark J, Albertioni F, Hassan M, Pettersson B, Juliusson G: On the bioavailability of oral and subcutaneous 2-chloro-2′-deoxyadenosine in humans: Alternative routes of administration. J Clin Oncol 10:1514, 1992
-
(1992)
J Clin Oncol
, vol.10
, pp. 1514
-
-
Liliemark, J.1
Albertioni, F.2
Hassan, M.3
Pettersson, B.4
Juliusson, G.5
|